Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI

For Life and Money: How to Make Money by Making Life Longer and Better

To build sustainable longevity biotechnology ecosystem - check out these four books to understand how biotechnology works

May 22 • Alex Zhavoronkov

50

9

How Much Can You Extend Your Life with Drugs?

I asked every frontier AI model the same simple question: how many years of healthy life can drugs actually buy us? The answers were humbling — and the…

May 8 • Alex Zhavoronkov

75

12

5

April 2026

Peakspan: The True North of Longevity and Why We Must Aim Beyond Healthspan

Welcome to the Post-Healthspan Era: Peakspan is the Essential Metric for the Longevity Century

Apr 9 • Alex Zhavoronkov

58

8

1

January 2026

The Next Battlefield in Frontier AI Will Be in AI for Science

The ultimate benchmarks will be experimentally and clinically validated therapeutics

Jan 30 • Alex Zhavoronkov

25

1

Pharma, Biotechnology, and Longevity: 2025 Year in Review

Scientific Progress, Clinical Outcomes, and Regulatory Approvals

Jan 26 • Alex Zhavoronkov

54

5

3

Woke Longevity: How the Healthspan vs. Lifespan Debate Masks Real Problems

How do you make important problems go away? Simple—make unimportant issues important.

Jan 20 • Alex Zhavoronkov

41

16

December 2025

Longevity Couture: Can we Make Longevity Clothing Fashionable?

Notes from Milan and Hong Kong on longevity wear: dressing up for long life and the twelve commandments of longevity couture

Dec 22, 2025 • Alex Zhavoronkov

18

7

2

November 2025

The "Swiss Army Knife" Longevity Target NLRP3 Strikes Again

This post is not an investment advise or any form of endorsement of any of the drugs. To my knowledge, all of the NLRP3 drugs are investigational and…

Nov 4, 2025 • Alex Zhavoronkov

11

2

2

October 2025

The Ozempic For Sleep? How A New Class of ‘On/Off’ Switch Drugs Could Help With Insomnia and Ward Off Dementia

My Favorite Drug and My Next Favorite Anti-Drug: A Personal Journey into Sleep Optimization

Oct 28, 2025 • Alex Zhavoronkov

21

5

1

September 2025

AI as a Stakeholder: What Every Pharma CEO Should Know About Communicating with AI

Communicating with AI today and in the future may require new levels of intensity, transparency, and communication mediums

Sep 23, 2025 • Alex Zhavoronkov

19

1

GLP-1s: The world's first longevity drug?

The "DeepSeek Moment" in the longevity biotechnology we've all been waiting for transpired on August 29, 2025 at the 12th ARDD meeting in Copenhagen

Sep 9, 2025 • Alex Zhavoronkov

45

2

2

August 2025

Beyond GLP-1: Is NLRP3 the Next Trillion Dollar Target?

This 24-year-old target demonstrates promise across multiple chronic diseases and has been prioritized by two AI-driven longevity companies. The quality…

Aug 12, 2025 • Alex Zhavoronkov

46

4

1